Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Bohte R et al. |
Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8593024
|
Tribble D et al. |
Efficacy of azithromycin for typhoid fever. |
1995 |
Clin. Infect. Dis. |
pmid:8645805
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Kuzman I et al. |
Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. |
1995 |
Scand. J. Infect. Dis. |
pmid:8588143
|
Patton DL et al. |
The activity of azithromycin on the infectivity of Chlamydia trachomatis in human amniotic cells. |
1995 |
J. Antimicrob. Chemother. |
pmid:8821594
|
Ramadan MA et al. |
Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. |
1995 |
J. Med. Microbiol. |
pmid:7752216
|
Martin DH et al. |
Comparison of azithromycin and ceftriaxone for the treatment of chancroid. |
1995 |
Clin. Infect. Dis. |
pmid:8562752
|
Kieserman SP et al. |
Streptococcal pharyngitis: alternative treatments. |
1995 |
Ear Nose Throat J |
pmid:8536567
|
van Rijsoort-Vos JH et al. |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. |
1995 |
J. Antimicrob. Chemother. |
pmid:8537268
|
Tajima T et al. |
[Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin]. |
1995 |
Jpn J Antibiot |
pmid:7474329
|
Fujii R et al. |
[Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin]. |
1995 |
Jpn J Antibiot |
pmid:7474330
|
al-Assi MT et al. |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. |
1995 |
Am. J. Gastroenterol. |
pmid:7872278
|
Andersen SL et al. |
Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. |
1995 |
Am. J. Trop. Med. Hyg. |
pmid:7872444
|
Stamm WE et al. |
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. |
1995 |
JAMA |
pmid:7629982
|
Schmid GP and Fontanarosa PB |
Evolving strategies for management of the nongonococcal urethritis syndrome. |
1995 |
JAMA |
pmid:7629989
|
Sadiq ST et al. |
Effects of azithromycin on malariometric indices in The Gambia. |
1995 |
Lancet |
pmid:7564674
|
Wawer MJ et al. |
AIDS intervention in Uganda. |
1995 |
Science |
pmid:7570005
|
Gastearena I et al. |
Determination of the alpha1-acid glycoprotein binding of azithromycin in vitro by equilibrium dialysis. |
1995 |
J Chemother |
pmid:8904095
|
Van Asselt GJ et al. |
Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro. |
1995 |
J. Med. Microbiol. |
pmid:7563004
|